|
KHSRP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.076210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.434400E-04 |
| Normal-vs-Stage2 |
3.337600E-01 |
| Normal-vs-Stage3 |
9.567800E-02 |
| Normal-vs-Stage4 |
7.162400E-01 |
| Stage1-vs-Stage2 |
3.417600E-01 |
| Stage1-vs-Stage3 |
2.103700E-03 |
| Stage1-vs-Stage4 |
5.180000E-02 |
| Stage2-vs-Stage3 |
5.411700E-02 |
| Stage2-vs-Stage4 |
3.568000E-01 |
| Stage3-vs-Stage4 |
4.962000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.817600E-02 |
| Normal-vs-AfricanAmerican |
1.615770E-01 |
| Normal-vs-Asian |
6.472600E-01 |
| Caucasian-vs-AfricanAmerican |
9.341200E-01 |
| Caucasian-vs-Asian |
7.709200E-01 |
| AfricanAmerican-vs-Asian |
7.879400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.981400E-03 |
| Normal-vs-Female |
2.323200E-01 |
| Male-vs-Female |
1.461920E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.567800E-01 |
| Normal-vs-Extreme_Weight |
2.358200E-04 |
| Normal-vs-Obese |
5.412200E-01 |
| Normal-vs-Extreme_Obese |
6.559400E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.557800E-02 |
| Normal_Weight-vs-Obese |
1.731180E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.162400E-01 |
| Extreme_Weight-vs-Obese |
1.461570E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.715800E-01 |
| Obese-vs-Extreme_Obese |
1.204060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.965750E-02 |
| Normal-vs-Age(41-60Yrs) |
5.948200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.379010E-03 |
| Normal-vs-Age(81-100Yrs) |
3.376100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.381640E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.279100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.795100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.480700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.550370E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.737180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.464200E-03 |
| Normal-VS-Type2 PRCC |
2.074100E-02 |
| Normal-VS-KIRP CIMP |
1.055790E-02 |
| Normal-VS-Unclassified PRCC |
6.180800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.721000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.901100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.446100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.200200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.549600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.170100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.105980E-01 |
| Normal-vs-N1 |
1.004250E-02 |
| Normal-vs-N2 |
7.499400E-01 |
| N0-vs-N1 |
1.759900E-03 |
| N0-vs-N2 |
7.205600E-01 |
| N1-vs-N2 |
2.207600E-01 |
|
|
